Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1962;26:7-11

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KONG, T. Q.
Right arrow Articles by HASERICK, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KONG, T. Q.
Right arrow Articles by HASERICK, J. R.

(Circulation. 1962;26:7.)
© 1962 American Heart Association, Inc.


Clinical Diagnosis of Cardiac Involvement in Systemic Lupus Erythematosus

A Correlation of Clinical and Autopsy Findings in Thirty Patients

THOMAS Q. KONG M.D.1; ROBERT E. KELLUM M.D.1; JOHN R. HASERICK M.D.1

1 From the Department of Cardiovascular Disease, and the Department of Dermatology, The Cleveland Clinic Foundation, Cleveland, Ohio.

A review was made of the case histories and autopsy reports of 30 patients with systemic lupus erythematosus who had clinical cardiovascular involvement. The presence of an enlarged heart or of gallop rhythm strongly suggests myocardial involvement, but the electrocardiogram is not specific. Signs and symptoms referable to the heart are unusual as a first manifestation of systemic lupus erythematosus, and in patients receiving suppressive chemotherapy they do not further worsen the prognosis. Systolic murmurs cannot be interpreted as conclusive evidence of Libman-Sacks valvulitis.




This article has been cited by other articles:


Home page
LupusHome page
A Afek, Y Shoenfeld, R Manor, I Goldberg, L Ziporen, J George, S Polak-Charcon, M C Amigo, R Garcia-Torres, R Segal, et al.
Increased endothelial cell expression of a3{beta}1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome
Lupus, September 1, 1999; 8(7): 502 - 507.
[Abstract] [PDF]


Home page
LupusHome page
Y. Farhey and E.V. Hess
Review : Grand Rounds from International Lupus Centres Accelerated atherosclerosis and coronary disease in SLE
Lupus, January 1, 1997; 6(7): 572 - 577.
[Abstract] [PDF]


Home page
CirculationHome page
M. Hojnik, J. George, L. Ziporen, and Y. Shoenfeld
Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome
Circulation, April 15, 1996; 93(8): 1579 - 1587.
[Abstract] [Full Text]


Home page
LupusHome page
P. R.J. Ames
Medical Perspective Antiphospholipid Antibodies, Thrombosis and Atherosclerosis in Systemic Lupus Erythematosus: a Unifying 'Membrane Stress Syndrome' Hypothesis
Lupus, October 1, 1994; 3(5): 371 - 377.
[PDF]